Editorial|Volume 14, Issue 6|pp 2438—2439

Targeting anxiety and senescence with senolytics

Marco Raffaele¹, Manlio Vinciguerra^1,²

¹International Clinical Research Center, St. Anne's University Hospital, Brno, Czech Republic
²Department of Translational Stem Cell Biology, Research Institute of the Medical University of Varna, Varna, Bulgaria

Received: March 4, 2022Accepted: March 25, 2022Published: March 27, 2022

https://doi.org/10.18632/aging.203985

Copyright: © 2022 Raffaele and Vinciguerra.This is an open access article distributed under the terms of the Creative Commons Attribution License (CC BY 3.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.